Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$201.05 - $221.7 $20,909 - $23,056
104 Added 1.26%
8,345 $1.68 Million
Q2 2023

Aug 03, 2023

BUY
$211.93 - $241.33 $295,430 - $336,414
1,394 Added 20.36%
8,241 $1.99 Million
Q1 2023

May 11, 2023

BUY
$213.32 - $257.83 $38,397 - $46,409
180 Added 2.7%
6,847 $1.57 Million
Q4 2022

Feb 13, 2023

BUY
$203.72 - $248.97 $1.36 Million - $1.66 Million
6,667 New
6,667 $1.57 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Paralel Advisors LLC Portfolio

Follow Paralel Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paralel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paralel Advisors LLC with notifications on news.